Detalles de la búsqueda
1.
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.
Respir Res
; 24(1): 316, 2023 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104098
2.
Cystic fibrosis and CFTR-related disorder with electrolyte imbalance at diagnosis: clinical features and outcome in an Italian cohort.
Eur J Pediatr
; 182(12): 5275-5283, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725210
3.
Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis.
Arch Gynecol Obstet
; 308(5): 1657-1659, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37517074
4.
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
Infection
; 50(3): 671-679, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874541
5.
Multiple, random spot urine sampling for estimating urinary sodium excretion.
Eur J Pediatr
; 181(1): 83-90, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196792
6.
Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
New Microbiol
; 43(3): 127-132, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656572
7.
Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.
Transpl Infect Dis
; 21(3): e13082, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892778
8.
Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.
Pediatr Nephrol
; 30(2): 345-52, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149851
9.
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting.
Pediatr Pulmonol
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38869349
10.
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis.
J Cyst Fibros
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729849
11.
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor combination: a 1-year observational study.
Ther Adv Respir Dis
; 18: 17534666241235054, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554035
12.
Effects of treatment in the levels of circulating cytokines and growth factors in cystic fibrosis and dialyzed patients by multi-analytical determination with a biochip array platform.
Cytokine
; 62(3): 413-20, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23608195
13.
Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment.
Pediatr Pulmonol
; 58(5): 1337-1343, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815622
14.
Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in cystic fibrosis: A matched cohort study.
Dig Liver Dis
; 55(3): 360-365, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36253246
15.
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes.
Diabetes Metab
; 49(5): 101466, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536552
16.
A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
Pediatr Pulmonol
; 57(11): 2868-2871, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36000266
17.
Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: An Italian single-center cross-sectional analysis.
Pediatr Pulmonol
; 57(1): 132-141, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636479
18.
Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies.
Biomedicines
; 10(8)2022 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36009545
19.
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy.
J Cyst Fibros
; 21(2): e113-e116, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949558
20.
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes.
Biomedicines
; 10(11)2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36359291